No amount of weight loss or specific clinical outcome can be guaranteed
Important considerations include: Individual responses vary considerablynot all patients experience reduced cravings Changes in food preferences may reflect general appetite suppression rather than specific effects on sugar craving Psychological and behavioural factors continue to influence eating patterns Long-term sustainability of any craving reduction after medication discontinuation is uncertain Patients should not rely solely on medication to manage sugar intake
Chandra, R., Hiniker, A., Kuo, Y
Sattele with new ones added regularly
Providers are increasingly seeing side effects such as: Nausea, vomiting, and delayed gastric emptying Fatigue and muscle loss during rapid weight loss Micronutrient depletion from reduced food intake Emotional dysregulation related to appetite and blood sugar swings Plateaus or weight regain after discontinuation Some patients also feel disconnected from their hunger cues or experience anxiety about long-term dependency on injections
In terms of patient characteristics, the reduction in prostate cancer risk with GLP-1RAs is more significant in older male patients, and the expression of endogenous GLP-1 receptors has been linked to cancer risk
